Log In
BCIQ
Print this Print this
 

VAL-1221 (formerly 4s3-004)

  Manage Alerts
Collapse Summary General Information
Company Valerion Therapeutics LLC
DescriptionChemical conjugation of the delivery antibody 3E10 with acid alpha glucosidase (GAA)
Molecular Target Acid alpha glucosidase (GAA)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentDiscovery
Standard IndicationPompe's disease
Indication DetailsTreat Pompe's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/04/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today